Alembic Pharma Q3 Results: Consolidated net profit declines 23% to ₹138 crore, stock down 5% | Stock Market News
Source: Live Mint Alembic Pharmaceuticals posted its results for the quarter ended December 2024 (Q3FY25). Its consolidated net profit tumbled 23.29 percent to ₹138.42 crore in Q3 FY25, compared with ₹180.45 crore posted in Q3 FY24. However, revenue from operations was at ₹1,692.74 crore in the third quarter of FY25, up 3.81 percent year on…
